The CHC is seeking comment from all members on the draft TGA consultation document ‘Evidence Required to Support Indications for Listed Medicines (excluding sunscreens and disinfectants). It is imperative that all members review the consultation document and make individual submission to the TGA in response to the proposed changes by Friday 25 May 2012. Provided at the following attachment are details of the major issues identified through the industry working group meeting, which will assist you in preparing your submission.
We also ask that you return your populated table (page 4) to Emma Burchell at technical@chc.org.au by COB, Wednesday 23rd of May. Please click here to view the Member Alert
